Skip to main content
Premium Trial:

Request an Annual Quote

'Heaven Knows What'

Forbes contributor Ted Greenwald envisions a promising future for synthetic genomics. As "commercial labs are redesigning industrial organisms such as yeast," while "students in MIT's synthetic biology program are coding microbes using Lego-style biological components known as BioBricks, and DIY clubs are doing heaven knows what," Greenwald says he expects it won't be long before researchers are using genomics to engineer, among other things, "algae that produce carbon-neutral fuel. Bugs that filter polluted water. A new generation of biodegradeable materials. Crops that thrive in salty, dry, or flooded soil."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.